PubMed:12933807 / 98-297 JSONTXT

{"project":"sentences","denotations":[{"id":"T2","span":{"begin":0,"end":199},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In pathological corneas, accumulation of fibrotic extracellular matrix is characterized by proteoglycans with altered glycosaminoglycans that contribute to the reduced transparency of scarred tissue."}

{"project":"GlyCosmos15-UBERON","denotations":[{"id":"T3","span":{"begin":16,"end":23},"obj":"Body_part"},{"id":"T4","span":{"begin":50,"end":70},"obj":"Body_part"},{"id":"T5","span":{"begin":192,"end":198},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/UBERON_0000964"},{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/GO_0031012"},{"id":"A5","pred":"uberon_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/UBERON_0000479"}],"text":"In pathological corneas, accumulation of fibrotic extracellular matrix is characterized by proteoglycans with altered glycosaminoglycans that contribute to the reduced transparency of scarred tissue."}

{"project":"sentences","denotations":[{"id":"T2","span":{"begin":0,"end":199},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In pathological corneas, accumulation of fibrotic extracellular matrix is characterized by proteoglycans with altered glycosaminoglycans that contribute to the reduced transparency of scarred tissue."}

{"project":"GlyCosmos15-Sentences","blocks":[{"id":"T2","span":{"begin":0,"end":199},"obj":"Sentence"}],"text":"In pathological corneas, accumulation of fibrotic extracellular matrix is characterized by proteoglycans with altered glycosaminoglycans that contribute to the reduced transparency of scarred tissue."}

{"project":"Anatomy-UBERON","denotations":[{"id":"T3","span":{"begin":16,"end":23},"obj":"Body_part"},{"id":"T4","span":{"begin":50,"end":70},"obj":"Body_part"},{"id":"T5","span":{"begin":192,"end":198},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/UBERON_0000964"},{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/GO_0031012"},{"id":"A5","pred":"uberon_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/UBERON_0000479"}],"text":"In pathological corneas, accumulation of fibrotic extracellular matrix is characterized by proteoglycans with altered glycosaminoglycans that contribute to the reduced transparency of scarred tissue."}